|
CN109999030A
|
|
Tauro ursodesoxy cholic acid is used to treat the purposes of neurodegenerative disease
|
|
EP2251003A2
|
|
Ophthalmic Compositions for the Re-epithelialization, Healing and Disinfection of the Eye Tissues
|
|
EP2057983A1
|
|
Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations
|
|
WO9617938A1
|
|
Glycoproteins from herpes virus and vaccines containing them
|
|
WO9510294A1
|
|
Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
|
|
ITMI931196D0
|
|
Herpes virus glycoproteins and vaccines containing them
|
|
IT9021409D0
|
|
Compositions for use in animal husbandry.
|
|
IT9019398D0
|
|
A pharmaceutical composition a type of eye drops that act as an anti-inflammatory and the process used to prepare it.
|
|
IT8823076D0
|
|
Anti-Herpes vaccine
|
|
IT8820663D0
|
|
Photo-protective pharmaceutical compsn.
|
|
IT8820470D0
|
|
Retinoic acid-based ophthalmic formulation
|
|
IT8520010D0
|
|
Prodn. of bacterial extracts for vaccine mfr.
|
|
BE901885A
|
|
Stable ophthalmic soln. contg. N-acetyl-cysteine - prepd. in nitrogen satd. aq. buffer free of metal ions
|
|
IT8519252D0
|
|
Eye drops contg. isoxicam
|
|
BE899587A
|
|
Pharmaceutical composition of the eye drops with anti-inflammatory activity, and process for preparing the same.
|
|
IT8324181D0
|
|
Storage stable eye drops
|
